Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 8 of 8 entries
Sorted by: Best Match Show Resources per page
Role of viruses in oral squamous cell carcinoma.

Oncology reviews

Metgud R, Astekar M, Verma M, Sharma A.
PMID: 25992219
Oncol Rev. 2012 Sep 14;6(2):e21. doi: 10.4081/oncol.2012.e21. eCollection 2012 Oct 02.

The etiology of oral squamous cell carcinoma (OSCC) is complex and involves many factors. The most clearly defined risk factors are smoking and alcohol, which substantially increase the risk of oral SCC. However, despite this clear association, a substantial...

Cite
Metgud R, Astekar M, Verma M, et al. Role of viruses in oral squamous cell carcinoma. Oncol Rev. 2012;6(2):e21doi: 10.4081/oncol.2012.e21.
Metgud, R., Astekar, M., Verma, M., & Sharma, A. (2012). Role of viruses in oral squamous cell carcinoma. Oncology reviews, 6(2), e21. https://doi.org/10.4081/oncol.2012.e21
Metgud, Rashmi, et al. "Role of viruses in oral squamous cell carcinoma." Oncology reviews vol. 6,2 (2012): e21. doi: https://doi.org/10.4081/oncol.2012.e21
Metgud R, Astekar M, Verma M, Sharma A. Role of viruses in oral squamous cell carcinoma. Oncol Rev. 2012 Sep 14;6(2):e21. doi: 10.4081/oncol.2012.e21. eCollection 2012 Oct 02. PMID: 25992219; PMCID: PMC4419625.
Copy Download .nbib Format: NLM
Bioactive peptide design using the Resonant Recognition Model.

Nonlinear biomedical physics

Cosic I, Pirogova E.
PMID: 17908333
Nonlinear Biomed Phys. 2007 Jul 19;1(1):7. doi: 10.1186/1753-4631-1-7.

With a large number of DNA and protein sequences already known, the crucial question is to find out how the biological function of these macromolecules is "written" in the sequence of nucleotides or amino acids. Biological processes in any...

Cite
Cosic I, Pirogova E. Bioactive peptide design using the Resonant Recognition Model. Nonlinear Biomed Phys. 2007;1(1):7doi: 10.1186/1753-4631-1-7.
Cosic, I., & Pirogova, E. (2007). Bioactive peptide design using the Resonant Recognition Model. Nonlinear biomedical physics, 1(1), 7. https://doi.org/10.1186/1753-4631-1-7
Cosic, Irena, and Pirogova, Elena. "Bioactive peptide design using the Resonant Recognition Model." Nonlinear biomedical physics vol. 1,1 (2007): 7. doi: https://doi.org/10.1186/1753-4631-1-7
Cosic I, Pirogova E. Bioactive peptide design using the Resonant Recognition Model. Nonlinear Biomed Phys. 2007 Jul 19;1(1):7. doi: 10.1186/1753-4631-1-7. PMID: 17908333; PMCID: PMC1997124.
Copy Download .nbib Format: NLM
Belgian expert consensus for tumor-agnostic treatment of NTRK gene fusion-driven solid tumors with larotrectinib.

Critical reviews in oncology/hematology

Awada A, Berghmans T, Clement PM, Cuppens K, De Wilde B, Machiels JP, Pauwels P, Peeters M, Rottey S, Van Cutsem E.
PMID: 34861380
Crit Rev Oncol Hematol. 2021 Nov 30;169:103564. doi: 10.1016/j.critrevonc.2021.103564. Epub 2021 Nov 30.

Fusions of NTRK (neurotrophic tyrosine receptor kinase) genes with 5' partner genes can result in the expression of chimeric proteins that drive oncogenesis through ligand-independent kinase activation. Despite variable frequencies of NTRK fusions in different tumor types, the fact...

Cite
Awada A, Berghmans T, Clement PM, et al. Belgian expert consensus for tumor-agnostic treatment of NTRK gene fusion-driven solid tumors with larotrectinib. Crit Rev Oncol Hematol. 2021;169:103564doi: 10.1016/j.critrevonc.2021.103564.
Awada, A., Berghmans, T., Clement, P. M., Cuppens, K., De Wilde, B., Machiels, J. P., Pauwels, P., Peeters, M., Rottey, S., & Van Cutsem, E. (2021). Belgian expert consensus for tumor-agnostic treatment of NTRK gene fusion-driven solid tumors with larotrectinib. Critical reviews in oncology/hematology, 169103564. https://doi.org/10.1016/j.critrevonc.2021.103564
Awada, Ahmad, et al. "Belgian expert consensus for tumor-agnostic treatment of NTRK gene fusion-driven solid tumors with larotrectinib." Critical reviews in oncology/hematology vol. 169 (2021): 103564. doi: https://doi.org/10.1016/j.critrevonc.2021.103564
Awada A, Berghmans T, Clement PM, Cuppens K, De Wilde B, Machiels JP, Pauwels P, Peeters M, Rottey S, Van Cutsem E. Belgian expert consensus for tumor-agnostic treatment of NTRK gene fusion-driven solid tumors with larotrectinib. Crit Rev Oncol Hematol. 2021 Nov 30;169:103564. doi: 10.1016/j.critrevonc.2021.103564. Epub 2021 Nov 30. PMID: 34861380.
Copy Download .nbib Format: NLM
An immunocytochemical study of ras and myc oncoproteins and EGFr expression in pleural effusion smears.

Oncology reports

Athanassiadou P, Orphanidou D, Kyrkou K, Latsi P, Petrakakou E, Rasidakis A, Jordanoglou J.
PMID: 21594410
Oncol Rep. 1996 May;3(3):549-52. doi: 10.3892/or.3.3.549.

Pleural effusion smears from 112 patients with either benign or malignant lung disease were investigated for the expression of EGFr and the oncogene proteins myc p64 and ras p21. The streptavidin-biotin peroxidase technique was used. In the studied malignant...

Cite
Athanassiadou P, Orphanidou D, Kyrkou K, et al. An immunocytochemical study of ras and myc oncoproteins and EGFr expression in pleural effusion smears. Oncol Rep. 1996;3(3):549-52doi: 10.3892/or.3.3.549.
Athanassiadou, P., Orphanidou, D., Kyrkou, K., Latsi, P., Petrakakou, E., Rasidakis, A., & Jordanoglou, J. (1996). An immunocytochemical study of ras and myc oncoproteins and EGFr expression in pleural effusion smears. Oncology reports, 3(3), 549-52. https://doi.org/10.3892/or.3.3.549
Athanassiadou, P, et al. "An immunocytochemical study of ras and myc oncoproteins and EGFr expression in pleural effusion smears." Oncology reports vol. 3,3 (1996): 549-52. doi: https://doi.org/10.3892/or.3.3.549
Athanassiadou P, Orphanidou D, Kyrkou K, Latsi P, Petrakakou E, Rasidakis A, Jordanoglou J. An immunocytochemical study of ras and myc oncoproteins and EGFr expression in pleural effusion smears. Oncol Rep. 1996 May;3(3):549-52. doi: 10.3892/or.3.3.549. PMID: 21594410.
Copy Download .nbib Format: NLM
Belgian expert consensus for tumor-agnostic treatment of NTRK gene fusion-driven solid tumors with larotrectinib.

Critical reviews in oncology/hematology

Awada A, Berghmans T, Clement PM, Cuppens K, De Wilde B, Machiels JP, Pauwels P, Peeters M, Rottey S, Van Cutsem E.
PMID: 34861380
Crit Rev Oncol Hematol. 2021 Nov 30;103564. doi: 10.1016/j.critrevonc.2021.103564. Epub 2021 Nov 30.

Fusions of NTRK (neurotrophic tyrosine receptor kinase) genes with 5' partner genes can result in the expression of chimeric proteins that drive oncogenesis through ligand-independent kinase activation. Despite variable frequencies of NTRK fusions in different tumor types, the fact...

Cite
Awada A, Berghmans T, Clement PM, et al. Belgian expert consensus for tumor-agnostic treatment of NTRK gene fusion-driven solid tumors with larotrectinib. Crit Rev Oncol Hematol. 2021;103564doi: 10.1016/j.critrevonc.2021.103564.
Awada, A., Berghmans, T., Clement, P. M., Cuppens, K., De Wilde, B., Machiels, J. P., Pauwels, P., Peeters, M., Rottey, S., & Van Cutsem, E. (2021). Belgian expert consensus for tumor-agnostic treatment of NTRK gene fusion-driven solid tumors with larotrectinib. Critical reviews in oncology/hematology, 103564. https://doi.org/10.1016/j.critrevonc.2021.103564
Awada, Ahmad, et al. "Belgian expert consensus for tumor-agnostic treatment of NTRK gene fusion-driven solid tumors with larotrectinib." Critical reviews in oncology/hematology vol. (2021): 103564. doi: https://doi.org/10.1016/j.critrevonc.2021.103564
Awada A, Berghmans T, Clement PM, Cuppens K, De Wilde B, Machiels JP, Pauwels P, Peeters M, Rottey S, Van Cutsem E. Belgian expert consensus for tumor-agnostic treatment of NTRK gene fusion-driven solid tumors with larotrectinib. Crit Rev Oncol Hematol. 2021 Nov 30;103564. doi: 10.1016/j.critrevonc.2021.103564. Epub 2021 Nov 30. PMID: 34861380.
Copy Download .nbib Format: NLM
[Relationship between the expression of p53 and C-erbB-2 oncoproteins and biologic behaviors of human mucoepidermal carcinoma of salivary gland].

Shanghai kou qiang yi xue = Shanghai journal of stomatology

Lu MH, Du WD, Wei W, Wang CH.
PMID: 15048215
Shanghai Kou Qiang Yi Xue. 1999 Dec;8(4):217-20.

OBJECTIVE:To study the relationship between the expression of p53 and c-erbB-2 proteins and biologic behaviors of human mucoepidermal carcinoma.METHODS:The expressions of oncogene proteins p53 and c-erbB-2 in 32 cases of human mucoepidermal carcinomas were investigated with microwave immunohistochemistry.RESULTS:p53 and...

Cite
Lu MH, Du WD, Wei W, et al. [Relationship between the expression of p53 and C-erbB-2 oncoproteins and biologic behaviors of human mucoepidermal carcinoma of salivary gland]. Shanghai Kou Qiang Yi Xue. 1999;8(4):217-20
Lu, M. H., Du, W. D., Wei, W., & Wang, C. H. (1999). [Relationship between the expression of p53 and C-erbB-2 oncoproteins and biologic behaviors of human mucoepidermal carcinoma of salivary gland]. Shanghai kou qiang yi xue = Shanghai journal of stomatology, 8(4), 217-20.
Lu, M H, et al. "[Relationship between the expression of p53 and C-erbB-2 oncoproteins and biologic behaviors of human mucoepidermal carcinoma of salivary gland]." Shanghai kou qiang yi xue = Shanghai journal of stomatology vol. 8,4 (1999): 217-20.
Lu MH, Du WD, Wei W, Wang CH. [Relationship between the expression of p53 and C-erbB-2 oncoproteins and biologic behaviors of human mucoepidermal carcinoma of salivary gland]. Shanghai Kou Qiang Yi Xue. 1999 Dec;8(4):217-20. Chinese. PMID: 15048215.
Copy Download .nbib Format: NLM
Belgian expert consensus for tumor-agnostic treatment of NTRK gene fusion-driven solid tumors with larotrectinib.

Critical reviews in oncology/hematology

Awada A, Berghmans T, Clement PM, Cuppens K, De Wilde B, Machiels JP, Pauwels P, Peeters M, Rottey S, Van Cutsem E.
PMID: 34861380
Crit Rev Oncol Hematol. 2022 Jan;169:103564. doi: 10.1016/j.critrevonc.2021.103564. Epub 2021 Nov 30.

Fusions of NTRK (neurotrophic tyrosine receptor kinase) genes with 5' partner genes can result in the expression of chimeric proteins that drive oncogenesis through ligand-independent kinase activation. Despite variable frequencies of NTRK fusions in different tumor types, the fact...

Cite
Awada A, Berghmans T, Clement PM, et al. Belgian expert consensus for tumor-agnostic treatment of NTRK gene fusion-driven solid tumors with larotrectinib. Crit Rev Oncol Hematol. 2021;169:103564doi: 10.1016/j.critrevonc.2021.103564.
Awada, A., Berghmans, T., Clement, P. M., Cuppens, K., De Wilde, B., Machiels, J. P., Pauwels, P., Peeters, M., Rottey, S., & Van Cutsem, E. (2022). Belgian expert consensus for tumor-agnostic treatment of NTRK gene fusion-driven solid tumors with larotrectinib. Critical reviews in oncology/hematology, 169103564. https://doi.org/10.1016/j.critrevonc.2021.103564
Awada, Ahmad, et al. "Belgian expert consensus for tumor-agnostic treatment of NTRK gene fusion-driven solid tumors with larotrectinib." Critical reviews in oncology/hematology vol. 169 (2022): 103564. doi: https://doi.org/10.1016/j.critrevonc.2021.103564
Awada A, Berghmans T, Clement PM, Cuppens K, De Wilde B, Machiels JP, Pauwels P, Peeters M, Rottey S, Van Cutsem E. Belgian expert consensus for tumor-agnostic treatment of NTRK gene fusion-driven solid tumors with larotrectinib. Crit Rev Oncol Hematol. 2022 Jan;169:103564. doi: 10.1016/j.critrevonc.2021.103564. Epub 2021 Nov 30. PMID: 34861380.
Copy Download .nbib Format: NLM
Effects of endotoxin on expression of ras, p53 and bcl-2 oncoprotein in hepatocarcinogenesis induced by thioacetamide in rats.

World journal of gastroenterology

Yang JM, Han DW, Liang QC, Zhao JL, Hao SY, Ma XH, Zhao YC.
PMID: 27053867
World J Gastroenterol. 1997 Dec 15;3(4):213-7. doi: 10.3748/wjg.v3.i4.213.

AIM: To evaluate the relationship between expression of ras, p53 and bcl-2 gene products and hepatocarcinogenesis since the endotoxemia produced from lipopolysaccharide administration and/or the hypophagocytic state of splenectomy significantly accelerated hepatocarcinogenesis induced by thioacetamide.METHODS: The hepatocarcinoma model was...

Cite
Yang JM, Han DW, Liang QC, et al. Effects of endotoxin on expression of ras, p53 and bcl-2 oncoprotein in hepatocarcinogenesis induced by thioacetamide in rats. World J Gastroenterol. 1997;3(4):213-7doi: 10.3748/wjg.v3.i4.213.
Yang, J. M., Han, D. W., Liang, Q. C., Zhao, J. L., Hao, S. Y., Ma, X. H., & Zhao, Y. C. (1997). Effects of endotoxin on expression of ras, p53 and bcl-2 oncoprotein in hepatocarcinogenesis induced by thioacetamide in rats. World journal of gastroenterology, 3(4), 213-7. https://doi.org/10.3748/wjg.v3.i4.213
Yang, J M, et al. "Effects of endotoxin on expression of ras, p53 and bcl-2 oncoprotein in hepatocarcinogenesis induced by thioacetamide in rats." World journal of gastroenterology vol. 3,4 (1997): 213-7. doi: https://doi.org/10.3748/wjg.v3.i4.213
Yang JM, Han DW, Liang QC, Zhao JL, Hao SY, Ma XH, Zhao YC. Effects of endotoxin on expression of ras, p53 and bcl-2 oncoprotein in hepatocarcinogenesis induced by thioacetamide in rats. World J Gastroenterol. 1997 Dec 15;3(4):213-7. doi: 10.3748/wjg.v3.i4.213. PMID: 27053867; PMCID: PMC4806235.
Copy Download .nbib Format: NLM
Showing 1 to 8 of 8 entries